Literature DB >> 19747473

Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays.

Philipp Schuetz1, Mirjam Christ-Crain, Andreas R Huber, Beat Müller.   

Abstract

OBJECTIVES: To assess long-term stability of PCT in deep-frozen samples and assess whether Kryptor procalcitonin cutoff ranges can be transferred on the bioMérieux VIDAS system. DESIGN AND METHODS: Samples from two intervention studies (ProRESP and ProCAP) were retested on both systems and compared with Passing-Bablok regression, Bland-Altman difference plot, and analysis of concordance over 4 medically relevant cutoff ranges.
RESULTS: Prolonged storage resulted in a significant decline of median procalcitonin values of 11.4% and 13.5% in ProRESP and ProCAP cohorts. Regression analysis showed that both methods correlated well (r=0.982, n=304) but with a deviation from the line of identity (y=1.234x-0.018). The Bland-Altman plot indicated an average relative bias of 17.1% (2 SD limits: -56.4% to 90.5%). Concordance over all 4 categories was 82.6%, without a significant difference in frequency distribution between methods.
CONCLUSION: An only modest decline of measured PCT levels of around 10% after long-term deep-frozen storage was found. The VIDAS procalcitonin assay showed good correlation and concordance with the established Kryptor method. Both techniques can be used with the same nominal procalcitonin cutoff ranges in clinical routine. (c) 2009 The Canadian Society of Clinical Chemists. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747473     DOI: 10.1016/j.clinbiochem.2009.08.029

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  21 in total

Review 1.  Procalcitonin in acute cardiac patients.

Authors:  Claudio Picariello; Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

2.  Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia.

Authors:  A Lacoma; N Rodríguez; C Prat; J Ruiz-Manzano; F Andreo; A Ramírez; A Bas; M Pérez; V Ausina; J Domínguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-26       Impact factor: 3.267

Review 3.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

4.  CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin.

Authors:  Tao Wang; Zhi-qin Wang; Lv Wang; Li Yan; Jian Wan; Sheng Zhang; Hong-quan Jiang; Wen-fang Li; Zhao-fen Lin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 5.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

6.  Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study.

Authors:  Cees van Nieuwkoop; Tobias N Bonten; Jan W van't Wout; Ed J Kuijper; Geert H Groeneveld; Martin J Becker; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Eliane M S Leyten; Jaap T van Dissel
Journal:  Crit Care       Date:  2010-11-17       Impact factor: 9.097

7.  Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure.

Authors:  Jody A Rule; Linda S Hynan; Nahid Attar; Corron Sanders; William J Korzun; William M Lee
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

8.  Procalcitonin levels associate with severity of Clostridium difficile infection.

Authors:  Krishna Rao; Seth T Walk; Dejan Micic; Elizabeth Chenoweth; Lili Deng; Andrzej T Galecki; Ruchika Jain; Itishree Trivedi; Marie Yu; Kavitha Santhosh; Cathrin Ring; Vincent B Young; Gary B Huffnagle; David M Aronoff
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  Procalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsis.

Authors:  Antonella Mencacci; Christian Leli; Angela Cardaccia; Marta Meucci; Amedeo Moretti; Francesco D'Alò; Senia Farinelli; Rita Pagliochini; Mariella Barcaccia; Francesco Bistoni
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

Review 10.  Biomarkers for sepsis: a review with special attention to India.

Authors:  George E Nelson; Vidya Mave; Amita Gupta
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.